BrightSpring Health Services (NASDAQ:BTSG) Sets New 12-Month High - Time to Buy?

Key Points

• BrightSpring hit a new 52‑week high intraday at $46.72 and was trading around $46.31 on volume of ~21,047 shares, above its 50‑ and 200‑day moving averages.
• Analysts are broadly bullish — the consensus rating is Buy with an average price target of $45.50, and several firms recently raised targets (as high as $52) or reaffirmed Outperform/Overweight ratings.
• Fundamentals are mixed: revenue rose 29.3% year‑over‑year but the quarter slightly missed EPS estimates, the stock trades at a high P/E (~52.6), and insiders sold about 285,000 shares (~$11.7M) in the past 90 days.

BrightSpring Health Services, Inc. (NASDAQ:BTSG - Get Free Report)'s share price hit a new 52-week high during mid-day trading on Tuesday . The company traded as high as $46.72 and last traded at $46.31, with a volume of 21047 shares changing hands. The stock had previously closed at $46.03.

Analyst Ratings Changes

BTSG has been the topic of a number of research analyst reports. TD Cowen reissued a "buy" rating on shares of BrightSpring Health Services in a research report on Monday, March 2nd. Mizuho upped their target price on shares of BrightSpring Health Services from $50.00 to $52.00 and gave the stock an "outperform" rating in a research report on Wednesday, March 18th. Morgan Stanley upped their target price on shares of BrightSpring Health Services from $40.00 to $48.00 and gave the stock an "overweight" rating in a research report on Wednesday, March 4th. Leerink Partners reaffirmed an "outperform" rating and issued a $49.00 target price on shares of BrightSpring Health Services in a research report on Wednesday, March 18th. Finally, BMO Capital Markets reaffirmed an "outperform" rating and issued a $46.00 target price on shares of BrightSpring Health Services in a research report on Friday, January 23rd. Two investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat, BrightSpring Health Services presently has a consensus rating of "Buy" and an average price target of $45.50.

BrightSpring Health Services Trading Up 0.1%

The firm has a market cap of $8.92 billion, a P/E ratio of 52.59, a price-to-earnings-growth ratio of 0.60 and a beta of 2.03. The stock has a fifty day simple moving average of $41.41 and a 200 day simple moving average of $37.17. The company has a debt-to-equity ratio of 1.32, a quick ratio of 1.12 and a current ratio of 1.57.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last posted its earnings results on Friday, February 27th. The company reported $0.33 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.34 by ($0.01). The company had revenue of $3.55 billion for the quarter, compared to the consensus estimate of $3.38 billion. BrightSpring Health Services had a net margin of 1.48% and a return on equity of 12.66%. BrightSpring Health Services's revenue was up 29.3% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.11 EPS. On average, research analysts expect that BrightSpring Health Services, Inc. will post 0.59 earnings per share for the current fiscal year.

Insider Buying and Selling at BrightSpring Health Services

In other BrightSpring Health Services news, CFO Jennifer A. Phipps sold 35,000 shares of the company's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $1,440,250.00. Following the transaction, the chief financial officer owned 196,840 shares in the company, valued at approximately $8,099,966. This represents a 15.10% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Lisa A. Nalley sold 30,000 shares of the company's stock in a transaction dated Wednesday, March 4th. The shares were sold at an average price of $41.15, for a total transaction of $1,234,500.00. Following the transaction, the insider owned 110,594 shares in the company, valued at $4,550,943.10. This represents a 21.34% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last 90 days, insiders have sold 285,000 shares of company stock worth $11,727,750. Company insiders own 3.40% of the company's stock.

Hedge Funds Weigh In On BrightSpring Health Services

Several institutional investors have recently made changes to their positions in the business. CWM LLC lifted its stake in shares of BrightSpring Health Services by 17.5% in the 4th quarter. CWM LLC now owns 1,874 shares of the company's stock worth $70,000 after purchasing an additional 279 shares during the period. EverSource Wealth Advisors LLC lifted its stake in shares of BrightSpring Health Services by 17.3% in the 4th quarter. EverSource Wealth Advisors LLC now owns 3,826 shares of the company's stock worth $143,000 after purchasing an additional 565 shares during the period. NBC Securities Inc. bought a new position in shares of BrightSpring Health Services in the 4th quarter worth approximately $29,000. Salomon & Ludwin LLC bought a new position in shares of BrightSpring Health Services in the 4th quarter worth approximately $30,000. Finally, Farther Finance Advisors LLC lifted its stake in shares of BrightSpring Health Services by 112.8% in the 4th quarter. Farther Finance Advisors LLC now owns 1,717 shares of the company's stock worth $64,000 after purchasing an additional 910 shares during the period.

About BrightSpring Health Services

BrightSpring Health Services NASDAQ: BTSG is a leading provider of home and community-based care and workforce solutions aimed at seniors, individuals with disabilities and those facing behavioral health challenges. The company's operations encompass a broad spectrum of services, including personal care, skilled nursing, therapy, habilitation and supported living, as well as specialized behavioral health programs delivered through both clinical and non-clinical channels.

Through its network of subsidiary brands, BrightSpring offers integrated care in the patient's home environment, fostering independence and improving quality of life.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.